Cargando…

A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma

EMAIL: zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com. BACKGROUND: Identifying patients at high risks of developing postoperative morbidity...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li-Yang, Zhu, Hong, Diao, Yong-Kang, Xing, Hao, Liang, Lei, Li, Jie, Zhou, Ya-Hao, Gu, Wei-Min, Chen, Ting-Hao, Zeng, Yong-Yi, Pawlik, Timothy M., Lau, Wan Yee, Li, Chao, Shen, Feng, Zhang, Cheng-Wu, Yang, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791207/
https://www.ncbi.nlm.nih.gov/pubmed/33437790
http://dx.doi.org/10.21037/atm-20-1421
_version_ 1783633561305219072
author Sun, Li-Yang
Zhu, Hong
Diao, Yong-Kang
Xing, Hao
Liang, Lei
Li, Jie
Zhou, Ya-Hao
Gu, Wei-Min
Chen, Ting-Hao
Zeng, Yong-Yi
Pawlik, Timothy M.
Lau, Wan Yee
Li, Chao
Shen, Feng
Zhang, Cheng-Wu
Yang, Tian
author_facet Sun, Li-Yang
Zhu, Hong
Diao, Yong-Kang
Xing, Hao
Liang, Lei
Li, Jie
Zhou, Ya-Hao
Gu, Wei-Min
Chen, Ting-Hao
Zeng, Yong-Yi
Pawlik, Timothy M.
Lau, Wan Yee
Li, Chao
Shen, Feng
Zhang, Cheng-Wu
Yang, Tian
author_sort Sun, Li-Yang
collection PubMed
description EMAIL: zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com. BACKGROUND: Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice. METHODS: Clinical data of patients who underwent hepatectomy for HCC at 8 hospitals from a multicenter database were retrospectively analyzed. The predictive accuracy of ALBI and APRI relative to 30-day overall and major morbidity were evaluated using area under the receiver operating characteristic curves (AUC). Based on multivariable logistic regression analyses, preoperative and postoperative nomogram models and consequent online calculators were constructed to predict overall and major morbidity, respectively. RESULTS: Among 2,301 patients, 725 (31.5%) experienced postoperative complications (major morbidity, 35.9%, 260/725). Multivariable analyses identified high ALBI grade (>−2.6) and APRI grade (>1.5) as independent risk factors associated with overall and major morbidity in both preoperative and postoperative prediction models. Two nomogram predictive models and corresponding online calculators that combined ALBI and APRI were subsequently constructed. The AUCs of the preoperative and postoperative models were 0.728 and 0.742 to predict overall morbidity, and 0.739 and 0.713 to predict major morbidity, respectively, which were much higher than those of Child-Pugh score and the model for end-stage liver disease (MELD). Using the bootstrap validation method, the resulting models were internally validated well. CONCLUSIONS: Preoperative ALBI and APRI scores can predict postoperative morbidity following hepatectomy for HCC. An easy-to-use online calculator that combined ALBI and APRI was proposed for individually predicting the probabilities of postoperative overall and major morbidity before and immediately after surgery, so as to provide useful information to inform conversations about surgical risks.
format Online
Article
Text
id pubmed-7791207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-77912072021-01-11 A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma Sun, Li-Yang Zhu, Hong Diao, Yong-Kang Xing, Hao Liang, Lei Li, Jie Zhou, Ya-Hao Gu, Wei-Min Chen, Ting-Hao Zeng, Yong-Yi Pawlik, Timothy M. Lau, Wan Yee Li, Chao Shen, Feng Zhang, Cheng-Wu Yang, Tian Ann Transl Med Original Article EMAIL: zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com. BACKGROUND: Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice. METHODS: Clinical data of patients who underwent hepatectomy for HCC at 8 hospitals from a multicenter database were retrospectively analyzed. The predictive accuracy of ALBI and APRI relative to 30-day overall and major morbidity were evaluated using area under the receiver operating characteristic curves (AUC). Based on multivariable logistic regression analyses, preoperative and postoperative nomogram models and consequent online calculators were constructed to predict overall and major morbidity, respectively. RESULTS: Among 2,301 patients, 725 (31.5%) experienced postoperative complications (major morbidity, 35.9%, 260/725). Multivariable analyses identified high ALBI grade (>−2.6) and APRI grade (>1.5) as independent risk factors associated with overall and major morbidity in both preoperative and postoperative prediction models. Two nomogram predictive models and corresponding online calculators that combined ALBI and APRI were subsequently constructed. The AUCs of the preoperative and postoperative models were 0.728 and 0.742 to predict overall morbidity, and 0.739 and 0.713 to predict major morbidity, respectively, which were much higher than those of Child-Pugh score and the model for end-stage liver disease (MELD). Using the bootstrap validation method, the resulting models were internally validated well. CONCLUSIONS: Preoperative ALBI and APRI scores can predict postoperative morbidity following hepatectomy for HCC. An easy-to-use online calculator that combined ALBI and APRI was proposed for individually predicting the probabilities of postoperative overall and major morbidity before and immediately after surgery, so as to provide useful information to inform conversations about surgical risks. AME Publishing Company 2020-12 /pmc/articles/PMC7791207/ /pubmed/33437790 http://dx.doi.org/10.21037/atm-20-1421 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Sun, Li-Yang
Zhu, Hong
Diao, Yong-Kang
Xing, Hao
Liang, Lei
Li, Jie
Zhou, Ya-Hao
Gu, Wei-Min
Chen, Ting-Hao
Zeng, Yong-Yi
Pawlik, Timothy M.
Lau, Wan Yee
Li, Chao
Shen, Feng
Zhang, Cheng-Wu
Yang, Tian
A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
title A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
title_full A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
title_fullStr A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
title_full_unstemmed A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
title_short A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
title_sort novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791207/
https://www.ncbi.nlm.nih.gov/pubmed/33437790
http://dx.doi.org/10.21037/atm-20-1421
work_keys_str_mv AT sunliyang anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zhuhong anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT diaoyongkang anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT xinghao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lianglei anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lijie anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zhouyahao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT guweimin anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT chentinghao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zengyongyi anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT pawliktimothym anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lauwanyee anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lichao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT shenfeng anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zhangchengwu anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT yangtian anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT sunliyang novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zhuhong novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT diaoyongkang novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT xinghao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lianglei novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lijie novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zhouyahao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT guweimin novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT chentinghao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zengyongyi novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT pawliktimothym novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lauwanyee novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT lichao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT shenfeng novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT zhangchengwu novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma
AT yangtian novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma